Yasar, H. A. Et Al. 2020. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.2 , 267-272.

Yasar, H. A., Turna, H., Esin, E., Sedef, A. M., Alkan, A., Oksuzoglu, B., ... Ozdemir, N.(2020). Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.2, 267-272.

Yasar, HATİME Et Al. "Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.2, 267-272, 2020

Yasar, HATİME A. Et Al. "Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.2, pp.267-272, 2020

Yasar, H. A. Et Al. (2020) . "Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.2, pp.267-272.

@article{article, author={HATİME ARZU YAŞAR Et Al. }, title={Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={267-272} }